UTMD$59.435
Chart
Performance
Key Stats
AI UTMD Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyUtah Medical Products exhibits a solid fundamental profile with consistent profitability and a strong balance sheet. Thematic tailwinds in healthcare technology support long-term growth, although recent technical indicators suggest a period of consolidation. Overall, it presents a compelling investment opportunity for patient investors.
Thematic
Utah Medical Products operates in the healthcare technology sector, benefiting from trends in medical device innovation and an aging global population. While it holds a niche, the company's growth is tied to specific medical applications rather than broad, disruptive themes like AI.
Fundamental
Utah Medical Products demonstrates strong financial health with consistent profitability, healthy margins, and a robust balance sheet characterized by ample cash and low debt. Its valuation metrics are reasonable given its performance.
Technical
The stock is trading above its key long-term moving averages, suggesting an underlying bullish trend. However, recent performance shows a significant drop (-10.75% post-market), and several short-term technical indicators are mixed, pointing towards potential short-term volatility or consolidation.
| Factor | Score |
|---|---|
| Healthcare Technology Adoption | 75 |
| Aging Population & Chronic Diseases | 65 |
| Innovation in Medical Devices | 80 |
| Regulatory Landscape (Healthcare) | 60 |
| Market Niche Focus | 70 |
| Factor | Score |
|---|---|
| Valuation | 70 |
| Profitability | 95 |
| Growth | 30 |
| Balance Sheet Health | 100 |
| Cash Flow | 80 |
| Factor | Score |
|---|---|
| Trend Analysis | 75 |
| Momentum | 60 |
| Volume Confirmation | 60 |
| Support & Resistance | 60 |
| Recent Performance | 70 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Favorable P/E Ratio
The trailing Price-to-Earnings (P/E) ratio of 15.65 is below the industry average of 18, suggesting potential undervaluation relative to peers.
Positive Short-Term Performance
The stock has shown positive performance over the last 5 days (+3.74%) and 1 month (+1.3%), indicating recent positive investor sentiment.
Bearish Points (7)
Negative Long-Term Performance
The stock has experienced negative performance over the last 6 months (-7.76%) and 1 year (-13.13%), indicating recent underperformance and potential headwinds.
Bearish Moving Average Signals
Several key moving averages, including the 10-day and 20-day EMAs and SMAs, are signaling 'Sell', suggesting potential downward price pressure.
Calendar
June 2025
16
Ex-Dividend Date
July 2025
3
Next Dividend Date
July 2025
24
Next Earnings Date
H: $
A: $
L: $
Profile
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Seasonals
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
A leading medical technology company primarily focused on women's health, diagnostics, and surgical products, directly overlapping with UTMD's women's health focus.
Weight: 96
Its CooperSurgical division is a major global provider of products and services to the women's healthcare market, including fertility, obstetrics, and gynecology, making it a direct competitor.
Weight: 95
Global provider of medical technologies for critical care and surgery, including a significant portfolio of urology products, vascular access, and general surgical instruments, directly competing in UTMD's key areas.
Weight: 93
A large diversified medical technology company with segments including urology, surgical solutions, and medication management, offering direct and indirect competition.